Drug Shortage Report for CITALOPRAM
Report ID | 137023 |
Drug Identification Number | 02430568 |
Brand name | CITALOPRAM |
Common or Proper name | Citalopram Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CITALOPRAM |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2020-08-01 |
Estimated end date | |
Actual end date | 2021-05-06 |
Shortage status | Resolved |
Updated date | 2021-07-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-04-07 | English | Compare |
v2 | 2021-04-07 | French | Compare |
v3 | 2021-07-30 | English | Compare |
v4 | 2021-07-30 | French | Compare |
Showing 1 to 4 of 4